Skip to content

Using Non-Fluoroscopic Imaging Devices to Decrease Radiation Exposure During Ablation of Supraventricular Tachycardia

The Adjunct Use of Non-Fluoroscopic Imaging Devices to Decrease Radiation Exposure During Ablation of Supraventricular Tachycardia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00979303
Enrollment
74
Registered
2009-09-18
Start date
2009-01-09
Completion date
2010-05-28
Last updated
2018-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supraventricular Tachycardia

Keywords

Pediatric, Electrophysiology, Ablation, Radiation, Devices, SVT

Brief summary

The purpose of this study is to determine whether the additional use of non-fluoroscopic imaging modalities can decrease the use of radiation exposure during standard ablation procedures for supraventricular tachycardia (SVT) in children.

Detailed description

The standard of care for children undergoing SVT ablation is radiation (fluoroscopy) to see the heart. Non fluoroscopic imaging tools have been utilized for adult atrial fibrillation procedures. These tools utilize magnetic fields to visualize the heart without using radiation. The purpose of this study was to determine if these 3D mapping tools could reduce radiation exposure during SVT ablation procedures could be performed using these 3D tools.

Interventions

DEVICEIntracardiac echocardiography and 3D navigational system

Patients assigned to the intervention group will receive both intracardiac echocardiography as well as a 3D navigational system in addition to fluoroscopy during their ablation procedure.

Sponsors

Boston Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Intent to treat use of non fluoroscopic mapping system with traditional fluoroscopic mapping system during elective catheter ablation in children 8-17 with normal cardiac anatomy

Eligibility

Sex/Gender
ALL
Age
8 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

* Age \>/=8 * Weight \>/=25kg * Structurally normal heart (no major cardiac defects) * History of SVT * No prior history of cardiac surgery or ablation

Exclusion criteria

* Congenital Heart Disease * Prior history of cardiac surgery or ablation

Design outcomes

Primary

MeasureTime frameDescription
Total Fluoroscopy TimeDuring the Ablation procedureTotal fluoroscopy time in minutes

Secondary

MeasureTime frameDescription
Total Radiation ExposureDuring Ablation ProcedureTotal radiation exposure measured in mGy

Countries

United States

Participant flow

Participants by arm

ArmCount
Control Group
Control Patients - Undergo ablation procedures with radiation/fluoroscopy only
37
Study Group
Study Group Patients - Undergo ablation procedures using intracardiac echocardiography and 3D navigational system in addition to radiation. Intracardiac echocardiography and 3D navigational system: Patients assigned to the intervention group will receive both intracardiac echocardiography as well as a 3D navigational system in addition to fluoroscopy during their ablation procedure.
37
Total74

Baseline characteristics

CharacteristicControl GroupStudy GroupTotal
Age, Categorical
<=18 years
37 Participants35 Participants72 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants2 Participants2 Participants
Age, Continuous14.2 years14.7 years14.5 years
BMI21.4 kg/m^222.3 kg/m^221.9 kg/m^2
BSA1.6 m^21.6 m^21.6 m^2
Chest circumference17.4 cm17.5 cm17.4 cm
Height162 cm162.2 cm162.1 cm
Region of Enrollment
United States
37 participants37 participants74 participants
Sex: Female, Male
Female
20 Participants18 Participants38 Participants
Sex: Female, Male
Male
17 Participants19 Participants36 Participants
Weight57.9 kg59.1 kg58.5 kg

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 370 / 37
other
Total, other adverse events
8 / 376 / 37
serious
Total, serious adverse events
0 / 370 / 37

Outcome results

Primary

Total Fluoroscopy Time

Total fluoroscopy time in minutes

Time frame: During the Ablation procedure

ArmMeasureValue (MEDIAN)
Control GroupTotal Fluoroscopy Time18.3 minutes
Study GroupTotal Fluoroscopy Time7.5 minutes
Secondary

Total Radiation Exposure

Total radiation exposure measured in mGy

Time frame: During Ablation Procedure

ArmMeasureValue (MEDIAN)
Control GroupTotal Radiation Exposure387 mGy
Study GroupTotal Radiation Exposure110 mGy

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026